N-butyldeoxynojirimycin Reduces Growth of Mouse Brain Tumours
Author Information
Author(s): Ranes M K, El-Abbadi M, Manfredi M G, Mukherjee P, Platt F M, Seyfried T N
Primary Institution: Department of Biology, Boston College
Hypothesis
Can N-butyldeoxynojirimycin inhibit the growth and ganglioside content of brain tumours?
Conclusion
N-butyldeoxynojirimycin significantly reduces the growth and ganglioside content of mouse brain tumours.
Supporting Evidence
- N-butyldeoxynojirimycin inhibited the proliferation of brain tumour cells by 50%.
- The drug reduced the growth of subcutaneous and intracerebral tumours by at least 50%.
- N-butyldeoxynojirimycin treatment shifted the distribution of tumour gangliosides.
Takeaway
A special sugar called N-butyldeoxynojirimycin can help slow down the growth of brain tumours in mice.
Methodology
The study involved administering N-butyldeoxynojirimycin to mice and measuring its effects on tumour growth and ganglioside composition.
Limitations
The study was conducted on mice, which may not fully represent human responses.
Participant Demographics
Adult syngeneic C57BL/6 mice were used in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website